- Category
- Micro (2024-25)
- Udyam number
- UDYAM-WB-10-0084908

MG Pharmaceuticals Private Limited
About MG Pharmaceuticals Private Limited
Data last updated:
MG Pharmaceuticals Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 04 December 1996 and has been in existence for over 30 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24232WB1996PTC082177.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Manoj Gupta and Swati Gupta.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 10C Middleton Row1St Floor, Kolkata, West Bengal, India – 700071.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.99 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹78.72 Lakh (net margin 19.7%) and EBITDA of ₹78.72 Lakh (EBITDA margin 19.7%). Revenue has grown at a compounded annual rate (CAGR) of 205% over three years and 337% over five years.
MG Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-10-0084908). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of MG Pharmaceuticals
Contact details
MG Pharmaceuticals Private Limited's registered office is in Kolkata, West Bengal. Its e-mail address is in the company report.
- Email
- Registered Address10C Middleton Row1St Floor, Kolkata, West Bengal, India – 700071
- IndustryHealthcare, Preventive Health Services
To see the full contact details of MG Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of MG Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of MG Pharmaceuticals Private Limited, buy the company report.
Financials of MG Pharmaceuticals Private Limited
FY 2024 filings availableMG Pharmaceuticals Private Limited reported revenue of ₹3.99 Cr (up 499225% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 337% over five years. EBITDA rose 136% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹78.72 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹78.72 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 19.7% | ||||
| Net Profit Margin | 19.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of MG Pharmaceuticals Private Limited, buy the company report.
Board of directors of MG Pharmaceuticals Private Limited
MG Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manoj Gupta | Director | 04 Dec 1996 | 29 Years 10 Months | Current |
| Swati Gupta | Director | 04 Dec 1996 | 29 Years 10 Months | Current |
Auditor
MG Pharmaceuticals Private Limited is audited by AGRAWAL & CO for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AGRAWAL & CO | FY 2018 | 303051E |
Shareholding
The shareholding of MG Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of MG Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving MG Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for MG Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for MG Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
MG Pharmaceuticals Private Limited has 2 board changes on record since 1996: 2 appointments. The latest: Manoj Gupta was appointed as Director on 04 Dec 1996.
Frequently asked questions
MG Pharmaceuticals is an active private limited company based in Kolkata, West Bengal, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 04 December 1996 (30+ years old) and is registered under CIN U24232WB1996PTC082177.
MG Pharmaceuticals has 2 current directors:
- Manoj Gupta - Director
- Swati Gupta - Director
The latest financial statements of MG Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of MG Pharmaceuticals is U24232WB1996PTC082177. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
MG Pharmaceuticals was incorporated on 04 December 1996, making it 30+ years old. It is registered with the Registrar of Companies, Kolkata.
Manoj Gupta was appointed as Director on 04 Dec 1996. Swati Gupta was appointed as Director on 04 Dec 1996.
Yes, MG Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-WB-10-0084908).
The registered office of MG Pharmaceuticals is at 10C Middleton Row1St Floor, Kolkata, West Bengal, India – 700071.
MG Pharmaceuticals operates in the healthcare industry, in the preventive health services segment.
The compliance status of MG Pharmaceuticals is compliant as of 10 July 2026. The company is actively filing with the Registrar of Companies.